세계의 카나비노이드(Cannabinoids) 시장 보고서(2025년)

Cannabinoids are specific chemical compounds found in marijuana that exert effects on the immune and central nervous systems similar to certain drugs. These compounds are utilized to alleviate side effects or symptoms associated with chronic diseases, particularly in the context of cancer treatment.

The primary types of cannabinoid products include cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol, and other variants. Cannabidiol is employed in the treatment of conditions such as seizures, anxiety, insomnia, chronic pain, and tobacco addiction. It is a chemical component derived from the cannabis sativa plant or hemp. The distribution channels for cannabinoids encompass hospital pharmacies, retail pharmacies, and online stores. Applications for cannabinoids span medical, recreational, and industrial hemp uses.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cannabinoids protection market research report is one of a series of new reports from The Business Research Company that provides cannabinoids market statistics, including cannabinoids industry global market size, regional shares, competitors with a cannabinoids market share, detailed cannabinoids market segments, market trends and opportunities, and any further data you may need to thrive in the cannabinoids industry. This cannabinoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cannabinoids market size has grown rapidly in recent years. It will grow from $39.45 billion in 2024 to $47.03 billion in 2025 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to medical cannabis legalization, increasing acceptance of cannabis, research and development, regulatory changes, growing awareness of cannabinoid benefits, investments in cannabis industry, consumer trends toward natural products.

The cannabinoids market size is expected to see exponential growth in the next few years. It will grow to $99.82 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to wider legalization and decriminalization, research advancements, diverse product offerings, international market expansion, public health awareness initiatives. Major trends in the forecast period include increasing acceptance and destigmatization, diversification of product offerings, innovation in delivery methods, quality and safety standards, social equity and inclusivity initiatives.

The forecast of 20.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. pain management by increasing costs for Food and Drug Administration(FDA)-approved cannabis-derived medications and standardized CBD formulations imported from Portugal and Israel, potentially reducing alternative pain therapy options. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the cannabinoid market. Chronic diseases are long-lasting conditions that typically require ongoing medical care. A systematic review of randomized controlled trials examined the effectiveness of cannabinoids, including smoked marijuana, oromucosal extracts of cannabis-based medications, nabilone, dronabinol, and a new THC analogue, in managing chronic noncancer pain. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that 41 million deaths, or 74% of global deaths, were caused by non-communicable diseases (NCDs) or chronic diseases annually. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the cannabinoid market.

The rising prevalence of cancer is expected to drive the growth of the cannabinoid market. Cancer is a condition in which some of the body's cells grow uncontrollably and spread to other parts of the body. Cannabinoids are increasingly used to support cancer patients by managing symptoms such as neuropathy, nausea, pain, vomiting, appetite loss, and weight loss. Additionally, cannabinoids can influence cancer progression by stimulating autophagy and affecting signaling pathways that lead to apoptosis (cell death). For example, in January 2022, the American Cancer Society reported an estimated 1,918,030 new cancer cases and 609,360 cancer-related deaths in the United States. Among these, around 350 people are expected to die each day from lung cancer, which remains the leading cause of cancer-related deaths. As a result, the increasing prevalence of cancer is contributing to the growth of the cannabinoid market.

Major companies in the cannabinoids market are strategically focusing on introducing advanced cannabis-based cosmetic solutions to gain a competitive edge. Cannabis-based cosmetic solutions, like CBG and CBD rescue cream, are formulated with cannabis derivatives to offer skin moisturizing, anti-aging, and anti-inflammatory effects. For instance, in November 2022, British Cannabis, a UK-based producer, introduced the Synergy CBG and CBD Rescue Cream, the first cannabis cosmetic in the UK to undergo clinical trials. This innovative product reflects a commitment to creating comprehensive skincare solutions in the cannabinoid market.

Major companies in the cannabinoids market are focusing on developing innovative solutions like fast-acting cannabinoids to enhance the efficacy and speed of therapeutic effects. Fast-acting cannabinoids refer to formulations that deliver quicker relief compared to traditional methods. For example, in August 2024, Rare Cannabinoid, a US-based health and wellness company, launched Fast-Acting Nano THC + CBC Mood Mints. These mints provide rapid effects, allowing users to feel the benefits of delta-9-THC and cannabichromene (CBC) within 15 to 30 minutes, compared to the usual 30 to 90 minutes for traditional edibles. Using advanced nanotechnology, the mints offer customizable dosing options, ideal for microdosing and personalized use.

In January 2022, Dermapharm Holding SE, a Germany-based pharmaceutical company, acquired C3 Group for an undisclosed amount. The acquisition aimed to strengthen Dermapharm Holding's position in the growing cannabis market by enhancing its cannabinoid production capabilities, expanding its distribution channels across Europe, and deepening its expertise in therapeutic solutions for serious medical conditions. This move comes as regulatory changes increasingly favor the acceptance of medical cannabis. C3 Group, a Poland-based company, specializes in cannabinoid compounds, contributing to Dermapharm's strategic push into this emerging sector.

Major companies operating in the cannabinoids market are The Supreme Cannabis Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC., Tilray Inc., Aurora Cannabis Inc., Innovative Ind Props, Curaleaf Holdings Inc., Green Thumb Industries, Verano Holdings, Trulieve Cannabis Corp., Cresco Labs Inc., Cronos Group, TerrAscend Corp., Canopy Growth Corp., Sundial Growers Inc., Decibel Cannabis Company, Auxly Cannabis Group, Red White & Bloom Brands, BZAM Ltd, Delta 9 Cannabis Inc., Mylan N.V., Westleaf Cannabis Inc., GrowGeneration, The Scotts Miracle-Gro Company, Jazz Pharmaceuticals PLC, Aphria Inc., Organigram Inc., Alkem labs, MediPharm Labs Corp., The Valens GroWorks Inc.

North America was the largest region in the cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cannabinoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cannabinoids market consists of sales of cannabidiolic acid, flowers/buds and concentrates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cannabinoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cannabinoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cannabinoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cannabinoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Cannabidiol; Tetrahydrocannabinol; Cannabinol; Other Product Types
• 2) By Distribution: Hospital Pharmacies; Retail Pharmacies; Online Stores
• 3) By Application: Medical; Recreational; Industrial Hemp
• Subsegments:
• 1) By Cannabidiol (CBD): Full-Spectrum CBD; Broad-Spectrum CBD; CBD Isolate
• 2) By Tetrahydrocannabinol (THC): Delta-9 THC; Delta-8 THC
• 3) By Cannabinol (CBN): CBN Isolate; CBN Oil
• 4) By Other Product Types: Cannabigerol (CBG); Cannabichromene (CBC); Terpenes And Other Phytocannabinoids
• Companies Mentioned: The Supreme Cannabis Company Inc.; Elixinol Global Limited; GW Pharmaceuticals PLC.; Tilray Inc.; Aurora Cannabis Inc.; Innovative Ind Props; Curaleaf Holdings Inc.; Green Thumb Industries; Verano Holdings; Trulieve Cannabis Corp.; Cresco Labs Inc.; Cronos Group; TerrAscend Corp.; Canopy Growth Corp.; Sundial Growers Inc.; Decibel Cannabis Company; Auxly Cannabis Group; Red White & Bloom Brands; BZAM Ltd; Delta 9 Cannabis Inc.; Mylan N.V.; Westleaf Cannabis Inc.; GrowGeneration; The Scotts Miracle-Gro Company; Jazz Pharmaceuticals PLC; Aphria Inc.; Organigram Inc.; Alkem labs; MediPharm Labs Corp.; The Valens GroWorks Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cannabinoids Market Characteristics

3. Cannabinoids Market Trends And Strategies

4. Cannabinoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cannabinoids Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cannabinoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cannabinoids Market Growth Rate Analysis
• 5.4. Global Cannabinoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cannabinoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cannabinoids Total Addressable Market (TAM)

6. Cannabinoids Market Segmentation

• 6.1. Global Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cannabidiol
• Tetrahydrocannabinol
• Cannabinol
• Other Product Types
• 6.2. Global Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• 6.3. Global Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical
• Recreational
• Industrial Hemp
• 6.4. Global Cannabinoids Market, Sub-Segmentation Of Cannabidiol (CBD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Full-Spectrum CBD
• Broad-Spectrum CBD
• CBD Isolate
• 6.5. Global Cannabinoids Market, Sub-Segmentation Of Tetrahydrocannabinol (THC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Delta-9 THC
• Delta-8 THC
• 6.6. Global Cannabinoids Market, Sub-Segmentation Of Cannabinol (CBN), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBN Isolate
• CBN Oil
• 6.7. Global Cannabinoids Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Terpenes And Other Phytocannabinoids

7. Cannabinoids Market Regional And Country Analysis

• 7.1. Global Cannabinoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cannabinoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cannabinoids Market

• 8.1. Asia-Pacific Cannabinoids Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cannabinoids Market

• 9.1. China Cannabinoids Market Overview
• 9.2. China Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cannabinoids Market

• 10.1. India Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cannabinoids Market

• 11.1. Japan Cannabinoids Market Overview
• 11.2. Japan Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cannabinoids Market

• 12.1. Australia Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cannabinoids Market

• 13.1. Indonesia Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cannabinoids Market

• 14.1. South Korea Cannabinoids Market Overview
• 14.2. South Korea Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cannabinoids Market

• 15.1. Western Europe Cannabinoids Market Overview
• 15.2. Western Europe Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cannabinoids Market

• 16.1. UK Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cannabinoids Market

• 17.1. Germany Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cannabinoids Market

• 18.1. France Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cannabinoids Market

• 19.1. Italy Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cannabinoids Market

• 20.1. Spain Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cannabinoids Market

• 21.1. Eastern Europe Cannabinoids Market Overview
• 21.2. Eastern Europe Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cannabinoids Market

• 22.1. Russia Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cannabinoids Market

• 23.1. North America Cannabinoids Market Overview
• 23.2. North America Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cannabinoids Market

• 24.1. USA Cannabinoids Market Overview
• 24.2. USA Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cannabinoids Market

• 25.1. Canada Cannabinoids Market Overview
• 25.2. Canada Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cannabinoids Market

• 26.1. South America Cannabinoids Market Overview
• 26.2. South America Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cannabinoids Market

• 27.1. Brazil Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cannabinoids Market

• 28.1. Middle East Cannabinoids Market Overview
• 28.2. Middle East Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cannabinoids Market

• 29.1. Africa Cannabinoids Market Overview
• 29.2. Africa Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cannabinoids Market Competitive Landscape And Company Profiles

• 30.1. Cannabinoids Market Competitive Landscape
• 30.2. Cannabinoids Market Company Profiles
  • 30.2.1. The Supreme Cannabis Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Elixinol Global Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GW Pharmaceuticals PLC. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Tilray Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aurora Cannabis Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cannabinoids Market Other Major And Innovative Companies

• 31.1. Innovative Ind Props
• 31.2. Curaleaf Holdings Inc.
• 31.3. Green Thumb Industries
• 31.4. Verano Holdings
• 31.5. Trulieve Cannabis Corp.
• 31.6. Cresco Labs Inc.
• 31.7. Cronos Group
• 31.8. TerrAscend Corp.
• 31.9. Canopy Growth Corp.
• 31.10. Sundial Growers Inc.
• 31.11. Decibel Cannabis Company
• 31.12. Auxly Cannabis Group
• 31.13. Red White & Bloom Brands
• 31.14. BZAM Ltd
• 31.15. Delta 9 Cannabis Inc.

32. Global Cannabinoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cannabinoids Market

34. Recent Developments In The Cannabinoids Market

35. Cannabinoids Market High Potential Countries, Segments and Strategies

• 35.1 Cannabinoids Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cannabinoids Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cannabinoids Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer